Additionally, circREEP3 inhibits anti‐tumor immunity by enhancing RNF125‐dependent degradation of RIG‐1, thereby regulating IFN‐β production and CD8+ T cell infiltration into the TME.234. The gene discussed is CD8A; the disease is neoplasm.